Compare ALEMBIC LTD with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs SUVEN LIFESCIENCES - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD SUVEN LIFESCIENCES ALEMBIC LTD/
SUVEN LIFESCIENCES
 
P/E (TTM) x 72.9 19.7 371.2% View Chart
P/BV x 2.6 4.0 65.1% View Chart
Dividend Yield % 0.4 0.5 74.3%  

Financials

 ALEMBIC LTD   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
SUVEN LIFESCIENCES
Mar-19
ALEMBIC LTD/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs72338 21.3%   
Low Rs34169 20.0%   
Sales per share (Unadj.) Rs4.752.1 9.0%  
Earnings per share (Unadj.) Rs6.16.8 89.4%  
Cash flow per share (Unadj.) Rs6.28.6 72.9%  
Dividends per share (Unadj.) Rs0.201.50 13.3%  
Dividend yield (eoy) %0.40.6 63.8%  
Book value per share (Unadj.) Rs40.765.3 62.3%  
Shares outstanding (eoy) m267.03127.28 209.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.34.9 231.6%   
Avg P/E ratio x8.737.1 23.4%  
P/CF ratio (eoy) x8.529.6 28.7%  
Price / Book Value ratio x1.33.9 33.5%  
Dividend payout %3.322.0 14.9%   
Avg Mkt Cap Rs m14,13932,272 43.8%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m207661 31.4%   
Avg. sales/employee Rs ThNM6,132.2-  
Avg. wages/employee Rs ThNM611.1-  
Avg. net profit/employee Rs ThNM803.5-  
INCOME DATA
Net Sales Rs m1,2556,635 18.9%  
Other income Rs m370242 152.8%   
Total revenues Rs m1,6256,877 23.6%   
Gross profit Rs m1111,604 6.9%  
Depreciation Rs m38221 17.1%   
Interest Rs m238 4.5%   
Profit before tax Rs m4421,587 27.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24718 3.3%   
Profit after tax Rs m1,630869 187.5%  
Gross profit margin %8.924.2 36.6%  
Effective tax rate %5.445.2 12.0%   
Net profit margin %129.813.1 990.9%  
BALANCE SHEET DATA
Current assets Rs m1,8676,232 30.0%   
Current liabilities Rs m5911,490 39.7%   
Net working cap to sales %101.671.5 142.2%  
Current ratio x3.24.2 75.5%  
Inventory Days Days9486 109.1%  
Debtors Days Days7483 89.0%  
Net fixed assets Rs m1,7914,043 44.3%   
Share capital Rs m534127 419.6%   
"Free" reserves Rs m10,3248,183 126.2%   
Net worth Rs m10,8588,310 130.7%   
Long term debt Rs m4118 231.5%   
Total assets Rs m11,59110,389 111.6%  
Interest coverage x260.943.1 605.2%   
Debt to equity ratio x00 177.1%  
Sales to assets ratio x0.10.6 17.0%   
Return on assets %14.18.7 161.2%  
Return on equity %15.010.5 143.5%  
Return on capital %15.219.5 77.8%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m195,622 0.3%   
Fx outflow Rs m2641,799 14.7%   
Net fx Rs m-2443,822 -6.4%   
CASH FLOW
From Operations Rs m236356 66.3%  
From Investments Rs m-224-279 80.4%  
From Financial Activity Rs m-27-225 11.8%  
Net Cashflow Rs m-15-148 10.0%  

Share Holding

Indian Promoters % 64.0 63.4 100.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.0 -  
FIIs % 9.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 36.5 71.5%  
Shareholders   54,701 37,287 146.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   J.B.CHEMICALS  AUROBINDO PHARMA  IPCA LABS  CADILA HEALTHCARE  SUN PHARMA  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps 470 Points; Energy and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended deep in the red. The BSE Sensex fell over 550 points intraday and breached the 36,000 mark.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Sep 19, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - PFIZER COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS